Stock research
CELC Celcuity Inc.
Healthcare • Biotechnology
Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with...…
Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.
ALL change
+331.68%
Range high
$144.98
Congress · 90d
0
Insiders · 90d
0
Public signal layer
Who is disclosing activity in CELC?
Price
Showing ALL history. Source: FMP historical price full.
- Prev Close
- $87.64
- Day High
- $88.50
- Day Low
- $85.46
- 52w High
- $151.02
- 52w Low
- $38.93
- Volume
- 677,931
- Avg Volume
- Beta
- 0.164
* TTM/most recent where available
Company
- Ticker
- CELC
- Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- US
- CEO
- Brian F. Sullivan
- Employees
- 155
- Website
- www.celcuity.com
Key Metrics
- Market Cap
- 4.21B
- P/E
- P/B
- P/S
- EV/EBITDA
- ROE
- Net Margin
- Div Yield
- FCF/Share
* TTM/most recent where available
DCF Valuation
Standard DCF
Levered DCF
Market Price
DCF vs Price (30D window)
Price uses last 30 days; DCF line holds latest value across the window.DCF line = solid green (latest value repeated across window), Price = dashed blue (daily closes).